Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

[Reliability of Commercial Tests for Hepatitis C Virus].

Shaw RH, Reddy KP, Coronel J, Moore DAJ.

Rev Medica Hered. 2018 Jan-Mar;29(1):60-63. doi: 10.20453/rmh.v29i1.3265. Spanish. No abstract available.

PMID:
29686475
2.

Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru.

Grandjean L, Gilman RH, Iwamoto T, Köser CU, Coronel J, Zimic M, Török ME, Ayabina D, Kendall M, Fraser C, Harris S, Parkhill J, Peacock SJ, Moore DAJ, Colijn C.

PLoS One. 2017 Dec 27;12(12):e0189838. doi: 10.1371/journal.pone.0189838. eCollection 2017.

3.

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity.

Paris L, Magni R, Zaidi F, Araujo R, Saini N, Harpole M, Coronel J, Kirwan DE, Steinberg H, Gilman RH, Petricoin EF 3rd, Nisini R, Luchini A, Liotta L.

Sci Transl Med. 2017 Dec 13;9(420). pii: eaal2807. doi: 10.1126/scitranslmed.aal2807.

4.

Interaction of the Lipopeptide Biosurfactant Lichenysin with Phosphatidylcholine Model Membranes.

Coronel JR, Marqués A, Manresa Á, Aranda FJ, Teruel JA, Ortiz A.

Langmuir. 2017 Sep 26;33(38):9997-10005. doi: 10.1021/acs.langmuir.7b01827. Epub 2017 Sep 8.

PMID:
28885026
5.

Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis.

Burke RM, Coronel J, Moore D.

J Med Microbiol. 2017 Jul;66(7):1023-1026. doi: 10.1099/jmm.0.000534.

PMID:
28759352
6.

Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.

Proaño A, Bravard MA, López JW, Lee GO, Bui D, Datta S, Comina G, Zimic M, Coronel J, Caviedes L, Cabrera JL, Salas A, Ticona E, Vu NM, Kirwan DE, Loader MI, Friedland JS, Moore DAJ, Evans CA, Tracey BH, Gilman RH; Tuberculosis Working Group in Peru.

Clin Infect Dis. 2017 May 1;64(9):1174-1181. doi: 10.1093/cid/cix039.

7.

Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection.

Dudley MZ, Sheen P, Gilman RH, Ticona E, Friedland JS, Kirwan DE, Caviedes L, Rodriguez R, Cabrera LZ, Coronel J, Grandjean L, Moore DA, Evans CA, Huaroto L, Chávez-Pérez V, Zimic M.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1239-1246. Epub 2016 Oct 24.

8.

A quantitative adaptation of the Wayne test for pyrazinamide resistance.

Meinzen C, Proaño A, Gilman RH, Caviedes L, Coronel J, Zimic M, Sheen P.

Tuberculosis (Edinb). 2016 Jul;99:41-6. doi: 10.1016/j.tube.2016.03.011. Epub 2016 Apr 6.

PMID:
27450003
9.

Protocol for studying cough frequency in people with pulmonary tuberculosis.

Proaño A, Bravard MA, Tracey BH, López JW, Comina G, Zimic M, Coronel J, Lee GO, Caviedes L, Cabrera JL, Salas A, Ticona E, Kirwan DE, Friedland JS, Evans CA, Moore DA, Gilman RH; Tuberculosis Working Group in Peru.

BMJ Open. 2016 Apr 22;6(4):e010365. doi: 10.1136/bmjopen-2015-010365. Erratum in: BMJ Open. 2016 May 25;6(5):e010365corr2. BMJ Open. 2016 May 04;6(5):e010365corr1.

10.

dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.

Moradigaravand D, Grandjean L, Martinez E, Li H, Zheng J, Coronel J, Moore D, Török ME, Sintchenko V, Huang H, Javid B, Parkhill J, Peacock SJ, Köser CU.

Antimicrob Agents Chemother. 2016 May 23;60(6):3864-7. doi: 10.1128/AAC.00253-16. Print 2016 Jun. No abstract available.

11.

Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?

Martin LJ, Roper MH, Grandjean L, Gilman RH, Coronel J, Caviedes L, Friedland JS, Moore DA.

BMC Med. 2016 Mar 23;14:30. doi: 10.1186/s12916-016-0576-8.

12.

Evaluation of a lens-free imager to facilitate tuberculosis diagnostics in MODS.

Solis L, Coronel J, Rueda D, Gilman RH, Sheen P, Zimic M.

Tuberculosis (Edinb). 2016 Mar;97:26-32. doi: 10.1016/j.tube.2015.12.001. Epub 2015 Dec 21.

PMID:
26980492
13.

The N400 reveals how personal semantics is processed: Insights into the nature and organization of self-knowledge.

Coronel JC, Federmeier KD.

Neuropsychologia. 2016 Apr;84:36-43. doi: 10.1016/j.neuropsychologia.2016.01.029. Epub 2016 Jan 26.

14.

Kinetic and Structural Aspects of the Permeabilization of Biological and Model Membranes by Lichenysin.

Coronel JR, Aranda FJ, Teruel JA, Marqués A, Manresa Á, Ortiz A.

Langmuir. 2016 Jan 12;32(1):78-87. doi: 10.1021/acs.langmuir.5b04294. Epub 2015 Dec 28.

PMID:
26652062
15.

The safety of drug treatments for cervical cancer.

Dueñas-González A, Cetina L, Coronel J, González-Fierro A.

Expert Opin Drug Saf. 2016;15(2):169-80. doi: 10.1517/14740338.2016.1130127. Epub 2015 Dec 30. Review.

PMID:
26650333
16.

Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study.

Grandjean L, Gilman RH, Martin L, Soto E, Castro B, Lopez S, Coronel J, Castillo E, Alarcon V, Lopez V, San Miguel A, Quispe N, Asencios L, Dye C, Moore DA.

PLoS Med. 2015 Jun 23;12(6):e1001843; discussion e1001843. doi: 10.1371/journal.pmed.1001843. eCollection 2015 Jun.

17.

The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru.

Grandjean L, Iwamoto T, Lithgow A, Gilman RH, Arikawa K, Nakanishi N, Martin L, Castillo E, Alarcon V, Coronel J, Solano W, Aminian M, Guezala C, Rastogi N, Couvin D, Sheen P, Zimic M, Moore DA.

PLoS One. 2015 May 18;10(5):e0126271. doi: 10.1371/journal.pone.0126271. eCollection 2015.

18.

A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.

Cetina L, Crombet T, Jiménez-Lima R, Zapata S, Ramos M, Avila S, Coronel J, Charco E, Bojalil R, Astudillo H, Bazán B, Dueñas-González A.

Cancer Biol Ther. 2015;16(5):684-9. doi: 10.1080/15384047.2015.1026483.

19.

Emerging drugs for the treatment of cervical cancer.

Serrano-Olvera A, Cetina L, Coronel J, Dueñas-González A.

Expert Opin Emerg Drugs. 2015 Jun;20(2):165-82. doi: 10.1517/14728214.2015.1002768. Epub 2015 Jan 12. Review.

PMID:
25578210
20.

New molecular targets against cervical cancer.

Duenas-Gonzalez A, Serrano-Olvera A, Cetina L, Coronel J.

Int J Womens Health. 2014 Dec 5;6:1023-31. doi: 10.2147/IJWH.S49471. eCollection 2014. Review.

21.

[Implementation of a telediagnostic system for tuberculosis and determination of multi-drug resistance based in the MODS method in Trujillo, Peru].

Rodríguez L, Alva A, Coronel J, Caviedes L, Mendoza-Ticona A, Gilman R, Sheen P, Zimic M.

Rev Peru Med Exp Salud Publica. 2014 Jul-Sep;31(3):445-53. Spanish.

22.

Follow-up consultations for cervical cancer patients in a Mexican cancer center. Comparison with NCCN guidelines.

Serrano-Olvera A, Cetina L, Coronel J, Duenas-Gonzalez A.

Asian Pac J Cancer Prev. 2014;15(20):8749-52.

23.

A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.

Martin L, Coronel J, Faulx D, Valdez M, Metzler M, Crudder C, Castillo E, Caviedes L, Grandjean L, Rodriguez M, Friedland JS, Gilman RH, Moore DA.

PLoS One. 2014 Sep 16;9(9):e107258. doi: 10.1371/journal.pone.0107258. eCollection 2014.

24.

Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis.

León-Cabrera S, Callejas BE, Ledesma-Soto Y, Coronel J, Pérez-Plasencia C, Gutiérrez-Cirlos EB, Ávila-Moreno F, Rodríguez-Sosa M, Hernández-Pando R, Marquina-Castillo B, Chirino YI, Terrazas LI.

Int J Biol Sci. 2014 Aug 24;10(9):948-56. doi: 10.7150/ijbs.9033. eCollection 2014.

25.

Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.

Dueñas-Gonzalez A, Coronel J, Cetina L, González-Fierro A, Chavez-Blanco A, Taja-Chayeb L.

Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1433-44. doi: 10.1517/17425255.2014.947263. Epub 2014 Aug 25. Review.

PMID:
25154405
26.

Participant attributions for global change ratings in unexplained chronic fatigue and chronic fatigue syndrome.

Friedberg F, Coronel J, Seva V, Adamowicz JL, Napoli A.

J Health Psychol. 2016 May;21(5):690-8. doi: 10.1177/1359105314535458. Epub 2014 Jun 8.

PMID:
24913009
27.

Task demands modulate decision and eye movement responses in the chimeric face test: examining the right hemisphere processing account.

Coronel JC, Federmeier KD.

Front Psychol. 2014 Mar 20;5:229. doi: 10.3389/fpsyg.2014.00229. eCollection 2014.

28.

Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.

Trollip AP, Moore D, Coronel J, Caviedes L, Klages S, Victor T, Romancenco E, Crudu V, Ajbani K, Vineet VP, Rodrigues C, Jackson RL, Eisenach K, Garfein RS, Rodwell TC, Desmond E, Groessl EJ, Ganiats TG, Catanzaro A.

Int J Tuberc Lung Dis. 2014 Feb;18(2):227-32. doi: 10.5588/ijtld.13.0229.

29.

Morphological characterization of Mycobacterium tuberculosis in a MODS culture for an automatic diagnostics through pattern recognition.

Alva A, Aquino F, Gilman RH, Olivares C, Requena D, Gutiérrez AH, Caviedes L, Coronel J, Larson S, Sheen P, Moore DA, Zimic M.

PLoS One. 2013 Dec 16;8(12):e82809. doi: 10.1371/journal.pone.0082809. eCollection 2013.

30.

New pharmacotherapy options for cervical cancer.

Dueñas-Gonzalez A, Cetina L, Coronel J, Cano C, Dolores R.

Expert Opin Pharmacother. 2014 Jan;15(1):51-60. doi: 10.1517/14656566.2014.855198. Epub 2013 Nov 9. Review.

PMID:
24206031
31.

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.

Coronel J, Roper MH, Herrera C, Bonilla C, Jave O, Gianella C, Sabogal I, Huancaré V, Leo E, Tyas A, Mendoza-Ticona A, Caviedes L, Moore DA.

Clin Microbiol Infect. 2014 Jun;20(6):536-41. doi: 10.1111/1469-0691.12401. Epub 2013 Nov 21.

32.

Chronic fatigue self-management in primary care: a randomized trial.

Friedberg F, Napoli A, Coronel J, Adamowicz J, Seva V, Caikauskaite I, Ngan MC, Chang J, Meng H.

Psychosom Med. 2013 Sep;75(7):650-7. doi: 10.1097/PSY.0b013e31829dbed4. Epub 2013 Aug 6.

33.

Tropical high-altitude Andean lakes located above the tree line attenuate UV-A radiation more strongly than typical temperate alpine lakes.

Aguilera X, Lazzaro X, Coronel JS.

Photochem Photobiol Sci. 2013 Sep;12(9):1649-57. doi: 10.1039/c3pp25285j.

PMID:
23722356
34.

A randomized comparison of cisplatin and oral vinorelbine as radiosensitizers in aged or comorbid locally advanced cervical cancer patients.

Coronel JA, Cetina Ldel C, Cantú D, Cerezo O, Hernández CS, Rivera L, Chacón AP, Duenas-Gonzalez A.

Int J Gynecol Cancer. 2013 Jun;23(5):884-9. doi: 10.1097/IGC.0b013e3182915c69.

PMID:
23694982
35.

Uterine sarcomas: review of 26 years at The Instituto Nacional de Cancerologia of Mexico.

Cantú de León D, González H, Pérez Montiel D, Coronel J, Pérez-Plasencia C, Villavicencio-Valencia V, Soto-Reyes E, Herrera LA.

Int J Surg. 2013;11(7):518-23. doi: 10.1016/j.ijsu.2013.04.013. Epub 2013 May 7. Review.

36.

Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.

Ugarte-Gil CA, Elkington P, Gilman RH, Coronel J, Tezera LB, Bernabe-Ortiz A, Gotuzzo E, Friedland JS, Moore DA.

PLoS One. 2013 Apr 22;8(4):e61333. doi: 10.1371/journal.pone.0061333. Print 2013.

37.

Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients.

Cetina L, González-Enciso A, Cantú D, Coronel J, Pérez-Montiel D, Hinojosa J, Serrano A, Rivera L, Poitevin A, Mota A, Trejo E, Montalvo G, Muñoz D, Robles-Flores J, de la Garza J, Chanona J, Jiménez-Lima R, Wegman T, Dueñas-González A.

Ann Oncol. 2013 Aug;24(8):2043-7. doi: 10.1093/annonc/mdt142. Epub 2013 Apr 21.

PMID:
23609186
38.

Event-related potential evidence suggesting voters remember political events that never happened.

Coronel JC, Federmeier KD, Gonsalves BD.

Soc Cogn Affect Neurosci. 2014 Mar;9(3):358-66. doi: 10.1093/scan/nss143. Epub 2012 Nov 30.

39.

Late recurrence of cervical cancer: a report of 16 cases.

Cetina L, Garcia-Arias A, Aguila C, Pérez D, Coronel J, Cantú D, Rivera L, Dueñas-González A.

Eur J Gynaecol Oncol. 2012;33(5):485-8.

PMID:
23185793
40.

Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru.

Iwamoto T, Grandjean L, Arikawa K, Nakanishi N, Caviedes L, Coronel J, Sheen P, Wada T, Taype CA, Shaw MA, Moore DA, Gilman RH.

PLoS One. 2012;7(11):e49651. doi: 10.1371/journal.pone.0049651. Epub 2012 Nov 21. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/a38090da-2437-4af0-b84a-0bb5de59805f.

41.

Remembering and Voting: Theory and Evidence from Amnesic Patients.

Coronel JC, Duff MC, Warren DE, Federmeier KD, Gonsalves BD, Tranel D, Cohen NJ.

Am J Pol Sci. 2012 Oct;56(4):837-848.

42.

Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay.

Fitzwater SP, Sechler GA, Jave O, Coronel J, Mendoza A, Gilman RH, Friedland JS, Moore DA.

Eur Respir J. 2013 May;41(5):1163-71. doi: 10.1183/09031936.00059812. Epub 2012 Aug 16.

43.

Cell therapy modulates expression of Tax1-binding protein 1 and synaptotagmin IV in a model of optic nerve lesion.

Mesentier-Louro LA, Coronel J, Zaverucha-do-Valle C, Mencalha A, Paredes BD, Abdelhay E, Mendez-Otero R, Santiago MF.

Invest Ophthalmol Vis Sci. 2012 Jul 12;53(8):4720-9. doi: 10.1167/iovs.11-8198.

PMID:
22695963
44.

Emerging drugs for cervical cancer.

Dueñas-Gonzalez A, Cetina L, Coronel J, Cervantes-Madrid D.

Expert Opin Emerg Drugs. 2012 Jun;17(2):203-18. doi: 10.1517/14728214.2012.683409. Epub 2012 Apr 25. Review.

PMID:
22530838
45.

Adenocarcinoma metastatic to the uterine cervix: a case series.

Pérez-Montiel D, Serrano-Olvera A, Salazar LC, Cetina-Pérez L, Candelaria M, Coronel J, Montalvo LA, de León DC.

J Obstet Gynaecol Res. 2012 Mar;38(3):541-9. doi: 10.1111/j.1447-0756.2011.01747.x. Epub 2012 Feb 22. Review.

PMID:
22353422
46.

Evaluation of bleach-sedimentation for sterilising and concentrating Mycobacterium tuberculosis in sputum specimens.

Chew R, Calderón C, Schumacher SG, Sherman JM, Caviedes L, Fuentes P, Coronel J, Valencia T, Hererra B, Zimic M, Huaroto L, Sabogal I, Escombe AR, Gilman RH, Evans CA.

BMC Infect Dis. 2011 Oct 11;11:269. doi: 10.1186/1471-2334-11-269.

47.

Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer.

Dueñas-Gonzalez A, Coronel J, Cetina L.

Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1601-12. doi: 10.1517/17425255.2011.625012. Epub 2011 Sep 28. Review.

PMID:
21955161
48.

F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.

Cetina L, Serrano A, Cantú-de-León D, Pérez-Montiel D, Estrada E, Coronel J, Hernández-Lucio M, Dueñas-González A.

Rev Invest Clin. 2011 May-Jun;63(3):227-35.

PMID:
21888286
49.

Inhaled salbutamol plus ipratropium in moderate and severe asthma crises in children.

Iramain R, López-Herce J, Coronel J, Spitters C, Guggiari J, Bogado N.

J Asthma. 2011 Apr;48(3):298-303. doi: 10.3109/02770903.2011.555037. Epub 2011 Feb 21.

PMID:
21332430
50.

Development of an automated MODS plate reader to detect early growth of Mycobacterium tuberculosis.

Comina G, Mendoza D, Velazco A, Coronel J, Sheen P, Gilman RH, Moore DA, Zimic M.

J Microsc. 2011 Jun;242(3):325-30. doi: 10.1111/j.1365-2818.2010.03477.x. Epub 2011 Jan 20.

Supplemental Content

Loading ...
Support Center